|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Nov 30, 2020
|
Q3 FY2020
As of Aug 31, 2020
|
Q2 FY2020
As of May 31, 2020
|
Q1 FY2020
As of Feb 29, 2020
|
Q4 FY2019
As of Nov 30, 2019
|
Q3 FY2019
As of Aug 31, 2019
|
Q2 FY2019
As of May 31, 2019
|
Q1 FY2019
As of Feb 28, 2019
|
Q4 FY2018
As of Nov 30, 2018
|
Q3 FY2018
As of Aug 31, 2018
|
Q2 FY2018
As of May 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Real estate assets at cost, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Real estate assets held for sale | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Real estate assets held for sale, net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Interest rate swap assets | ||||||||||||||||||||
| Assets of discontinued operations | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Mortgage loans, net of debt issuance costs | ||||||||||||||||||||
| Delayed draw term loan, net of debt issuance costs | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Revolving lines of credit | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Mortgage loan related to asset held for sale | ||||||||||||||||||||
| Interest rate swap liabilities | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Liabilities of discontinued operations | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Common stock, par value $0.01 per share, 50,000,000 shares authorized, 10,195,206 and 10,192,416 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Treasury stock, at cost, 617,816 shares | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
